Involvement of R-Ras and Ral GTPases in estrogen-independent proliferation of breast cancer cells

Oncogene

Volumn 21, Issue 49, 2002, Pages 7557-7568

  Yu, Yi ^a   Feig, Larry A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; R Ras; Ral

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; GUANOSINE TRIPHOSPHATASE; ONCOPROTEIN; PROTEIN KINASE B; PROTEIN R RAS; RAL PROTEIN; RAS PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVITY; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DIVISION; ESTROGENS; GTP PHOSPHOHYDROLASES; HUMANS; RAL GTP-BINDING PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0037168163     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205961     Document Type: Article

References (40)

1. Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G and Masciullo V. (1995). Int. J. Cancer, 64, 280-285.
2. Bielinski DF, Pyun NY, Linko-Stentz K, Macara I and Fine RE. (1993). Biochim. Biophys. Acta, 1151, 246-256.
3. Biscardi JS, Tice DA and Parsons SJ. (1999). Adv. Cancer Res., 76, 61-119.
4. Bos JL, de Rooij J and Reedquist KA. (2001). Nat. Rev. Mol. Cell. Biol., 2, 369-377.
5. Brymora A, Valova VA, Larsen MR, Roufogalis BD and Robinson PJ. (2001). J. Biol. Chem., 276, 29792-29796.
6. Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S and Nakshatri H. (2001). J. Biol. Chem., 276, 9817-9824.
7. Caron E, Self AJ and Hall A. (2000). Curr. Biol., 10, 974-978.
8. de Rooij J and Bos JL. (1997). Oncogene, 14, 623-625.
9. El-Ashry D, Miller DL, Kharbanda S, Lippman ME and Kern FG. (1997). Oncogene, 15, 423-435.
10. Gioanni J, Le Francois D, Zanghellini E, Mazeau C, Ettore F, Lambert JC, Schneider M and Dutrillaux B. (1990). Br. J. Cancer, 62, 8-13.
11. Goi T, Shipistin M, Lu Z, Foster DA, Klinz S and Feig LA. (2000). EMBO J., 19, 623-630.
12. Gotoh T, Cai D, Tian X, Feig LA and Lerner A. (2000). J. Biol. Chem., 275, 30118-30123.
13. Henry DO, Moskalenko SA, Kaur KJ, Fu M, Pestell RG, Camonis JH and White MA. (2000). Mol. Cell. Biol., 20, 8084-8092.
14. Johnston SR. (1997). Anticancer Drugs, 8, 911-930.
15. Kasid A, Lippman ME, Papageorge AG, Lowy DR and Gelmann EP. (1985). Science, 228, 725-728.
16. Keely PJ, Rusyn EV, Cox AD and Parise LV. (1999). J. Cell Biol., 145, 1077-1088.
17. Liu Y, el-Ashry D, Chen D, Ding IY and Kern FG. (1995). Breast Cancer Res. Treat., 34, 97-117.
18. Marte BM, Rodriguez-Viciana P, Wennstrom S, Warne PH and Downward J. (1997). Curr. Biol., 7, 63-70.
19. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E and Auricchio F. (1996). EMBO J., 15, 1292-1300.
20. Moskalenko S, Henry DO, Rosse C, Mirey G, Camonis JH and White MA. (2002). Nat. Cell Biol., 4, 66-72.
21. Nakashima S, Morinaka K, Koyama S, Ikeda M, Kishida M, Okawa K, Iwamatsu A, Kishida S and Kikuchi A. (1999). EMBO J., 18, 3629-3642.
22. Nakatani K, Thompson DA, Barthel A, Sakaue H, Liu W, Weigel RJ and Roth RA. (1999). J. Biol. Chem., 274, 21528-21532.
23. Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG and El-Ashry D. (2001). Mol. Endocrinol., 15, 1344-1359.
24. Ohtsuka T, Shimizu K, Yamamori B, Kuroda S and Takai Y. (1996). J. Biol. Chem., 271, 1253-1261.
25. Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX and Slamon DJ. (1995). Oncogene, 10, 2435-2446.
26. Polzin A, Shipitsin M, Goi T, Feig LA and Turner TJ. (2002). Mol. Cell Biol., 22, 1714-1722.
27. Riese 2nd DJ and Stern DF. (1998). Bioessays, 20, 41-48.
28. Rosario M, Paterson HF and Marshall CJ. (2001). Mol. Cell Biol., 21, 3750-3762.
29. Rusanescu G, Gotoh T, Tian X and Feig LA. (2001). Mol. Cell Biol., 21, 2650-2658.
30. Salh B, Marotta A, Wagey R, Sayed M and Pelech S. (2002). Int. J. Cancer, 98, 148-154.
31. Scott JA and McGuire WL. (1991). Endocrine-Dependent Tumors. Voight KD and Knabbe C (eds). New York: Raven Press Ltd, pp 179-196.
32. Takai Y, Sasaki T and Matozaki T. (2001). Physiol. Rev., 81, 153-208.
33. Tian X, Rusanescu G, Hou W, Schaffhausen B and Feig LA. (2002). EMBO J., 21, 1327-1338.
34. Turkson J and Jove R. (2000). Oncogene, 19, 6613-6626.
35. van Agthoven T, van Agthoven TL, Dekker A, van der Spek PJ, Vreede L and Dorssers LC. (1998). EMBO J., 17, 2799-2808.
36. van Agthoven T, van Agthoven TL, Portengen H, Foekens JA and Dorssers LC. (1992). Cancer Res., 52, 5082-5088.
37. Wang SC, Zhang L, Hortobagyi GN and Hung MC. (2001). Semin. Oncol., 28, 21-29.
38. Wiebe VJ, Osborne CK, Fuqua SA and DeGregorio MW. (1993). Crit. Rev. Oncol. Hematol., 14, 173-188.
39. Wolthuis RM, de Ruiter ND, Cool RH and Bos JL. (1997). EMBO J., 16, 6748-6761.
40. Zou JX, Wang B, Kalo MS, Zisch AH, Pasquale EB and Ruoslahti E. (1999). Proc. Natl. Acad. Sci. USA, 96, 13813-13818.